Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi
F
F
Neuromed Institute, Pozzilli (IS), Department of Neurological Science, University La Sapienza, Rome, Italy.
Fornai
F
F
Blandini
F
F
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism* / Q000503:physiopathology*; D001931:Brain Mapping; D002421:Caudate Nucleus / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D003847:Deoxyglucose / Q000378:metabolism*; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D009714:Nucleus Accumbens / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology*; D020734:Parkinsonian Disorders; D011699:Putamen / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism
D018491:Dopamine Agonists; D007980:Levodopa; D003847:Deoxyglucose; D004298:Dopamine